Keyphrases
Lipopolysaccharide-induced Lung Injury
100%
Podoplanin
100%
Acute Respiratory Distress Syndrome
57%
Lipopolysaccharide
57%
Intratracheal
42%
Alveolar Macrophages
42%
Lung Function Decline
28%
Lung Inflammation
28%
Chemokine Expression
28%
Beneficial Effects
28%
Intravenous Administration
14%
Mouse Model
14%
Endogenous Ligand
14%
Floxed
14%
Culture in Vitro
14%
Therapeutic Intervention
14%
Pulmonary Disease
14%
Bronchoalveolar Lavage
14%
In Vitro Activation
14%
Therapeutic Use
14%
Pulse Oximetry
14%
Inflammatory Chemokines
14%
Targeted Therapy
14%
Gene-deficient Mice
14%
Local Inflammation
14%
Neutrophil Recruitment
14%
Lipopolysaccharide-induced
14%
Critically Ill Patients
14%
Neutrophilia
14%
Patients at Risk
14%
C-type Lectin
14%
Platelets
14%
Immunology and Microbiology
Alveolar Macrophage
100%
Chemokine
100%
Pulmonary Inflammation
66%
Cytokine
66%
Cross Linking
66%
Secretion (Process)
33%
Pulse Rate
33%
Proinflammatory Cytokine
33%
Platelet
33%
Mouse Model
33%
Neutrophil
33%
C-Type Lectin
33%
Pharmacology, Toxicology and Pharmaceutical Science
Lipopolysaccharide
100%
Podoplanin
100%
Adult Respiratory Distress Syndrome
57%
Cytokine
42%
Chemokine
42%
Lipopolysaccharide-Induced Lung Inflammation
14%
Neutrophilia
14%
Lectin
14%
Therapeutic Use
14%
Mouse Model
14%
Inflammation
14%